- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
388 CHAPTER 8 Stone disease
Ureteric stones: diagnostic radiological imaging
The intravenous pyelogram (IVP), for many years the mainstay of imaging in patients with flank pain, has been replaced by CT urography (CTU) (Fig. 8.11). Compared with IVP, CTU
-Has greater specificity (95%) and sensitivity (97%) for diagnosing ureteric stones1—it can identify other, non-stone causes of flank pain (Fig. 8.12).
-Requires no contrast administration, avoiding the chance of a contrast reaction (risk of fatal anaphylaxis following the administration of lowosmolality contrast media for IVP is on the order of 1 in 100,000).2
-Is faster, taking just a few minutes to image the kidneys and ureters. An IVP, particularly when delayed films are required to identify a stone causing high-grade obstruction, may take hours to identify the precise location of the obstructing stone.
-Is equivalent in cost to that of IVP, in hospitals where high volumes of CT scans are done.3
If you only have access to IVP, remember that it is contraindicated in patients with a history of previous contrast reactions and should be avoided in those with hay fever, a strong history of allergies, or asthma who have not been pretreated with high-dose steroids 24 hours before the IVP. Patients taking metformin for diabetes should stop this for 48 hours prior to an IVP. Clearly, being able to perform an alternative test, such as CTU in such patients, is very useful.
Where 24-hour CTU access is not available, admit patients with suspected ureteric colic for pain relief and arrange for a CTU the following morning. When CT urography is not immediately available (between the hours of midnight and 8 a.m.), we obtain urgent abdominal ultrasonography in all patients aged >50 years who present with flank pain suggestive of a possible stone, to exclude serious pathology such as a leaking abdominal aortic aneurysm and to demonstrate any other gross abnormalities due to non-stone associated flank pain.
Plain abdominal X-ray and renal ultrasound are not sufficiently sensitive or specific for their routine use for diagnosing ureteric stones.
MR urography
MRU is a very accurate way of determining whether a stone is present in the ureter or not.4 However, cost and restricted availability limit its usefulness as a routine diagnostic method of imaging in cases of acute flank pain. This situation may change as MR scanners become more widely available.
1 Smith RC, Verga M, McCarthy S, Rosenfield AT (1996). Diagnosis of acute flank pain: value of unenhanced helical CT. Am J Roentgen 166:97–101.
2 Caro JJ, Trindale E, McGregor M (1991). The risks of death and severe non-fatal reactions with high vs low osmolality contrast media. Am J Roentgen 156:825–832.
3 Thomson JM, Glocer J, Abbott C, et al. (2001) Computed tomography versus intravenous urography in diagnosis of acute flank pain from urolithiasis: a randomized study comparing imaging costs and radiation dose. Australas Radiol 45:291–297.
4 Louca G, Liberopoulos K, Fidas A, et al. (1999) MR urography in the diagnosis of urinary tract obstruction. Eur Urol 35:102–108.
URETERIC STONES: DIAGNOSTIC RADIOLOGICAL IMAGING 389
Figure 8.11 CT urogram.
Figure 8.12 A leaking aortic aneurysm identified on a CTU in a patient with flank pain.
390 CHAPTER 8 Stone disease
Ureteric stones: acute management
While appropriate imaging studies are being organized, pain relief should be given.
-A nonsteroidal anti-inflammatory (NSAID) (e.g., diclofenac—Voltaren or ketorolac tromethamine—Toradol) by intramuscular or intravenous injection, by mouth or per rectum, provides rapid and effective pain control. Its analgesic effect is partly anti-inflammatory, partly by reducing ureteric peristalsis.
-When NSAIDs are inadequate, opiate analgesics such as dilaudid or morphine are added.
-Calcium channel antagonists (e.g., nifedipine) may reduce the pain of ureteric colic by reducing the frequency of ureteric contractions.1,2 This is used for upper ureteral stones, whereas A-blockers (e.g., Flomax and Uroxatral) may be used for distal ureteral stones.
There is no need to encourage the patient to drink copious amounts of fluids or to give them large volumes of fluids intravenously in the hope that this will flush out the stone. Renal blood flow and urine output from the affected kidney fall during an episode of acute, partial obstruction due to a stone.
Excess urine output will tend to cause a greater degree of hydronephrosis in the affected kidney, which will make ureteric peristalsis even less efficient than it already is. Peristalsis, the forward propulsion of a bolus of urine down the ureter, can only occur if the walls of the ureter above the bolus of urine can coapt, i.e., close firmly together. If they cannot, as occurs in a ureter distended with urine, the bolus of urine cannot move distally.
Watchful waiting
In many instances, small ureteric stones will pass spontaneously within days or a few weeks, with analgesic supplements for exacerbations of pain.
Chances of spontaneous stone passage depend principally on stone size. Between 90% and 98% of stones measuring <4 mm will pass spontaneously.3,4 Average time for spontaneous stone passage for stones 4–6 mm in diameter is 3 weeks.
Stones that have not passed in 2 months are unlikely to do so. Therefore, accurate determination of stone size (on plain abdominal X-ray or by CTU) helps predict chances of spontaneous stone passage.
1 B Borghi L, et al. (1994). Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomised, double-blind, placebo controlled study. J Urol 152:1095–1098.
2 Porpiglia F, et al. (2000). Effectiveness of nifedipine and deflazacort in the management of distal ureteric stones. Urology 56:579–582.
3 Segura JW, et al. (1997). Ureteral stones guidelines panel summary report on the management of ureteral calculi. J Urol 158:1915–1921.
4 Miller OF, et al. (1999). Time to stone passage for observed ureteral calculi. J Urol 162:688–691.
URETERIC STONES: ACUTE MANAGEMENT 391
Nifedipine1,2 and tamsulosin or alfuzosin (an A-adrenergic adrenoceptor blocking drug) may assist spontaneous stone passage and reduce frequency of ureteric colic.5 Nitroglycerine patches do not aid stone passage or reduce the frequency of pain episodes.6
5 Dellabella M, et al. (2003). Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202–2205.
6 Hussain Z, et al. (2001). Use of glyceryl trinitrate patches in patients with ureteral stones: a randomized, double-blind, placebo-controlled study. Urology 58:521–225.